drugset / Trial / NCT06120725

Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke

NCT06120725

Phase 3 Completed 580 enrolled Kafrelsheikh University
RandomizedParallel-groupDouble-blindTreatment

Summary

Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever large-vessel ischemic stroke compared to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.

Timeline

Start
2021-09-01
Primary completion
2023-09-01
Completion
2023-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Comparator Ticagrelor Small molecule 90 mg

Indications